Screening for Sleep Disordered Breathing and Sleep Disturbance Among Patients Recovered from COVID Infection

Overview

About this study

The purpose of this study is to compare prevalence of sleep apnea and sleep disturbance in post-COVID-19 infected patients who had been symptomatic to COVID negative participants as controls. A sleep testing device will assess for sleep disordered breathing and the results will be aggregated to compare if a significant increase (any difference) in the prevalence of sleep disordered breathing diagnosis between the two groups. Sleep questionnares data will be obtained. A second part of this study will involve using a Fitbit consumer wearable device to obtain sleep and activity data on participants for 2 months in duration.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Adults, ≥ 18 years of age.
COVID patients who had been treated at Mayo Clinic Florida hospital and recovered.
COVID negative patients as controls.

Exclusion Criteria:

Individuals under 18 years of age.
History of obstructive sleep apnea or sleep disordered breathing.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status
Jacksonville, Fla. Mayo Clinic principal investigator Joseph Cheung, M.D.	Closed for enrollment

Mayo Clinic Location

Status

Jacksonville, Fla.

Mayo Clinic principal investigator

Joseph Cheung, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Clinical Trials